Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Rheumatology|February 13, 2019
Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical studyFabiola Atzeni, Roberto Casale, Alessandra Alciati, et al.
Rheumatology and Therapy|December 24, 2024
Spondyloarthritis and Risk of Malignancy: A Narrative Review on a Still Controversial IssueEnnio Giulio Favalli, Francesco Grossi, Alberto Batticciotto, et al.
Clinical and Experimental Rheumatology|July 7, 2017
Psychosomatic syndromes in fibromyalgiaAda Ghiggia, Riccardo Torta, Valentina Tesio, et al.
Clinical and Experimental Rheumatology|June 28, 2023
Fibromyalgia: one year in review 2023Valeria Giorgi, Laura Bazzichi, Alberto Batticciotto, et al.
Frontiers in Urology|April 3, 2026
A rare case of penile granulomatosis with polyangiitis: case report and multidisciplinary management approachMatteo Coschignano, Nicolò Schifano, Benedetta Pennella, et al.
Advances in Therapy|July 26, 2018
Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED StudyPiercarlo Sarzi-Puttini, Emilio Filippucci, Silvano Adami, et al.
Clinical and Experimental Rheumatology|January 18, 2019
Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomesRossella Talotta, Vincenzo Mercurio, Sara Bongiovanni, et al.
Expert Review of Clinical Immunology|September 13, 2019
Medical cannabis and cannabinoids in rheumatology: where are we now?Piercarlo Sarzi-Puttini, Alberto Batticciotto, Fabiola Atzeni, et al.
ARP Rheumatology|October 1, 2025
Real-world efficacy and retention of guselkumab in psoriatic arthritis: insights from a 12-month multicenter studyNicola Farina, Nicola Boffini, Antonella Adinolfi, et al.
Clinical and Experimental Rheumatology|September 17, 2020
Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapyMaria Chiara Ditto, Simone Parisi, Valentina Varisco, et al.
Pageof 7